Stage-Specific Plasma Metabolomic Profiles in Colorectal Cancer

<b>Background/Objectives</b>: The objective of this study was to investigate the metabolomic profiles of patients with colorectal cancer (CRC) across various stages of the disease. <b>Methods</b>: The plasma samples were obtained from 255 subjects, including patients with CRC in stages I-IV, polyps, and controls. We employed capillary electrophoresis time-of-flight mass spectrometry and liquid chromatography triple quadrupole mass spectrometry to analyze hydrophilic metabolites comprehensively. The data were randomly divided into two groups, and consistent differences observed in both groups were analyzed. <b>Results</b>: Acetylated polyamines, such as <i>N</i>¹-acetylspermine and <i>N</i>¹, <i>N</i>¹²-diacetylspermine, consistently showed elevated concentrations in stage IV compared to stages I-III. Non-acetylated polyamines, including spermine and spermidine, exhibited increasing trends from polyp to stage IV. Other metabolites, such as histidine and o-acetylcarnitine, showed decreasing trends across stages. While acetylated polyamines have been reported as CRC detection markers, our findings suggest that they also possess diagnostic potential for distinguishing stage IV from other stages. <b>Conclusions</b>: This study showed stage-specific changes in metabolic profiles, including polyamines, of colorectal cancer.